Opat SS - Search Results

1

Molecular associations of response to the new-generation BTK inhibitor zanubrutinib in marginal zone lymphoma.

Tatarczuch M, Waltham M, Shortt J, Polekhina G, Hawkes EA, Ho SJ, Trotman J, Brasacchio D, Co M, Li J, Ramakrishnan V, Dunne K, Opat SS, Gregory GP. Tatarczuch M, et al. Among authors: opat ss. Blood Adv. 2023 Jul 25;7(14):3531-3539. doi: 10.1182/bloodadvances.2022009412. Blood Adv. 2023. PMID: 36947202 Free PMC article.

2

COVID-19 Infection in Patients With Chronic Lymphocytic Leukemia Receiving Acalabrutinib in the Phase 3B ASSURE Study.

Niemann CU, Awan FT, Fogliatto L, Nikitin E, Samoilova O, Habib A, Foroutanpour K, Kuptsova-Clarkson N, Opat S. Niemann CU, et al. Hemasphere. 2022 Sep 22;6(10):e780. doi: 10.1097/HS9.0000000000000780. eCollection 2022 Oct. Hemasphere. 2022. PMID: 36168519 Free PMC article. No abstract available.

3

Ibrutinib use, treatment duration, and concomitant medications in Australian patients with relapsed or refractory chronic lymphocytic leukaemia.

Mulligan SP, Opat S, Marlton P, Kuss B, Gerungan P, Puig A, McGeachie M, Tam CS. Mulligan SP, et al. Br J Haematol. 2022 Aug;198(4):790-793. doi: 10.1111/bjh.18306. Epub 2022 Jun 14. Br J Haematol. 2022. PMID: 35702012 No abstract available.

4

CD30:CD30 ligand interactions in the immune response.

Opat S, Gaston JS. Opat S, et al. Autoimmunity. 2000;33(1):45-60. doi: 10.3109/08916930108994109. Autoimmunity. 2000. PMID: 11204253 Review. No abstract available.

5

The oral iron chelator deferasirox inhibits NF-κB mediated gene expression without impacting on proximal activation: implications for myelodysplasia and aplastic anaemia.

Banerjee A, Mifsud NA, Bird R, Forsyth C, Szer J, Tam C, Kellner S, Grigg A, Motum P, Bentley M, Opat S, Grigoriadis G. Banerjee A, et al. Br J Haematol. 2015 Feb;168(4):576-82. doi: 10.1111/bjh.13151. Epub 2014 Oct 1. Br J Haematol. 2015. PMID: 25271366 Free article.

6

The thrombotic thrombocytopenic purpura registry: a new national resource to inform patient care and medical research.

Polizzotto MN, Phillips LE, Cannell P, Cohney S, Davies C, Opat SS, McNeil JJ, Wood EM. Polizzotto MN, et al. Among authors: opat ss. Intern Med J. 2009 Jan;39(1):72-3. doi: 10.1111/j.1445-5994.2008.01806.x. Intern Med J. 2009. PMID: 19290992 No abstract available.

7

Antiplatelet therapy: present status and future prospects.

Hamilton JR, Kaplan Z, Jackson SP, Opat S. Hamilton JR, et al. Expert Opin Drug Discov. 2007 Aug;2(8):1035-40. doi: 10.1517/17460441.2.8.1035. Expert Opin Drug Discov. 2007. PMID: 23484870

8

Complete remission of localised gastric plasmacytomas following definitive radiotherapy.

Tan J, Lade S, Harrison S, Opat S, Mac Manus MP. Tan J, et al. J Med Imaging Radiat Oncol. 2012 Jun;56(3):328-31. doi: 10.1111/j.1754-9485.2012.02369.x. Epub 2012 Apr 10. J Med Imaging Radiat Oncol. 2012. PMID: 22697332

9

A case of ITP with cauda equina syndrome.

Merriman E, Nandurkar D, Opat S, Tran H. Merriman E, et al. Ann Hematol. 2011 Jun;90(6):729-30. doi: 10.1007/s00277-010-1075-1. Epub 2010 Sep 18. Ann Hematol. 2011. PMID: 20852998 No abstract available.

10

Reply to Y. Song et al.

Dimopoulos MA, Opat S, Treon SP, Tam CS. Dimopoulos MA, et al. J Clin Oncol. 2024 Feb 1;42(4):482-484. doi: 10.1200/JCO.23.02162. Epub 2023 Dec 4. J Clin Oncol. 2024. PMID: 38048515 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

134 results

Search Page